Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Hematologic Neoplasms 5Vomiting 1Pain 1Nausea 1Anorexia 1

Interventions

Ondansetron 6Aprepitant 6Palonosetron 3Granisetron 3Dexamethasone 2Cyclophosphamide 2Calcium Dobesilate 2dexamethasone acetate 1dexamethasone 21-phosphate 1Sugars 1Olanzapine 1Immunoenzyme Techniques 1Drug Therapy 1Doxorubicin 1Control Groups 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nausea × Olanzapine × Other hematologic neoplasm × Clear all
NCT02116530 2025-01-28

Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
401 enrolled 14 charts
Other hematologic neoplasm

Nausea, Vomiting, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡